BLINCYTO recall in Canada: Benzyl alcohol toxicity risk for pediatric patients
In plain language
This recall involves BLINCYTO (blinatumomab) for injection sold in Canada. It's being recalled because it contains benzyl alcohol, which can cause serious and fatal adverse reactions in pediatric patients, especially neonates and infants. Healthcare professionals are advised to use preservative-free saline when preparing BLINCYTO for these patients.
What to do
- Healthcare professionals should only use preservative-free saline when preparing BLINCYTO for neonates, infants, and patients weighing less than 22 kg.
- Do not use the 7-day infusion bag option containing benzyl alcohol for these patients.
- Consider the total daily benzyl alcohol intake from all sources for patients.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
BLINCYTO (blinatumomab) for injection
Why this matters
Benzyl alcohol toxicity risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Benzyl alcohol toxicity risk
What should consumers do?
Healthcare professionals should only use preservative-free saline when preparing BLINCYTO for neonates, infants, and patients weighing less than 22 kg. Do not use the 7-day infusion bag option containing benzyl alcohol for these patients. Consider the total daily benzyl alcohol intake from all sources for patients.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Benzyl alcohol toxicity risk
When was this product recalled?
This product was recalled on June 12, 2018.
Is the BLINCYTO brand affected by this recall?
Yes, BLINCYTO products are affected by this recall. This recall involves BLINCYTO (blinatumomab) for injection sold in Canada. It's being recalled because it contains benzyl alcohol, which can cause serious and fatal adverse reactions in pediatric patients, especially neonates and infants. Healthcare professionals are advised to use preservative-free saline when preparing BLINCYTO for these patients.